Item 5.02. Departure of Directors or Certain Officers; Election of Directors;


            Appointment of Certain Officers; Compensatory Arrangements of Certain
            Officers.

(d) Incorporated by reference is a press release issued by Merck & Co., Inc. ("Merck" or the "Company") on January 31, 2020, attached as Exhibit 99.1, announcing the election of Kathy J. Warden and Christine E. Seidman, M.D. to the Company's Board of Directors (the "Board"), effective March 16, 2020. The Board appointed each of Ms. Warden and Dr. Seidman as a member of both the Audit Committee and the Research Committee of the Board.

For their service on the Board, Ms. Warden and Dr. Seidman will receive compensation as non-employee directors in accordance with the Company's non-employee director compensation practices described under the "Director Compensation" section of the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 8, 2019.

Neither Ms. Warden nor Dr. Seidman has any arrangements or understandings with any other person pursuant to which she was elected to the Board, nor does either of them have a relationship or related transaction with the Company that would require disclosure pursuant to Item 404(a) of Regulation S-K of the Securities and Exchange Commission in connection with her appointment as a director of the Company.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits



  99.1     Press Release issued January 31, 2020.
104.1    Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses